What is UroGen Pharma's net income?

UroGen Pharma (URGN) reported net income of -$23.57M in Q1 2026.

How has UroGen Pharma's net income changed year-over-year?

UroGen Pharma's net income increased by 46.2% year-over-year, from -$43.84M to -$23.57M.

What is the long-term trend for UroGen Pharma's net income?

Over 4 years (2021 to 2025), UroGen Pharma's net income has grown at a 8.5% compound annual growth rate (CAGR), from -$110.82M to -$153.49M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

UroGen Pharma URGN Net Income

Net Income at other companies

Bristol-Myers SquibbBMY

$2.68B+9.0%

PfizerPFE

$2.69B-9.4%

Johnson & JohnsonJNJ

$5.24B-52.4%

Merck & Co.MRK

-$4.24B-183%

ImmunityBio, Inc.IBRX

-$632.78M-388%

Tyra Biosciences, Inc.TYRA

-$39.31M-39.6%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's net income?: UroGen Pharma (URGN) reported net income of -$23.57M in Q1 2026.
How has UroGen Pharma's net income changed year-over-year?: UroGen Pharma's net income increased by 46.2% year-over-year, from -$43.84M to -$23.57M.
What is the long-term trend for UroGen Pharma's net income?: Over 4 years (2021 to 2025), UroGen Pharma's net income has grown at a 8.5% compound annual growth rate (CAGR), from -$110.82M to -$153.49M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.